Matinas BioPharma (NYSEAMERICAN:MTNB) Issues Earnings Results

Matinas BioPharma (NYSEAMERICAN:MTNB) announced its quarterly earnings results on Wednesday. The company reported ($0.03) EPS for the quarter, Yahoo Finance reports.

Matinas BioPharma Price Performance

Shares of MTNB opened at $0.28 on Thursday. Matinas BioPharma has a 12 month low of $0.11 and a 12 month high of $0.89.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the company. BlackRock Inc. raised its stake in shares of Matinas BioPharma by 0.7% in the first quarter. BlackRock Inc. now owns 4,325,053 shares of the company’s stock valued at $3,479,000 after acquiring an additional 29,643 shares during the last quarter. Atria Wealth Solutions Inc. bought a new position in shares of Matinas BioPharma in the first quarter valued at approximately $32,000. HRT Financial LP raised its stake in shares of Matinas BioPharma by 320.5% in the fourth quarter. HRT Financial LP now owns 54,567 shares of the company’s stock valued at $27,000 after acquiring an additional 41,590 shares during the last quarter. Renaissance Technologies LLC raised its stake in shares of Matinas BioPharma by 42.0% in the first quarter. Renaissance Technologies LLC now owns 171,929 shares of the company’s stock valued at $81,000 after acquiring an additional 50,833 shares during the last quarter. Finally, State Street Corp raised its stake in shares of Matinas BioPharma by 8.0% in the first quarter. State Street Corp now owns 712,471 shares of the company’s stock valued at $573,000 after acquiring an additional 52,897 shares during the last quarter. Institutional investors own 11.77% of the company’s stock.

Matinas BioPharma Company Profile

Matinas BioPharma Holdings, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides.